SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology: New and Renascent Themes

Neuroscientist

Volumn 21, Issue 5, 2015, Pages 519-529

  Bunton Stasyshyn, Rosie K A ^a   Saccon, Rachele A ^a   Fratta, Pietro ^a   Fisher, Elizabeth M C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ALS; amyotrophic lateral sclerosis; motor neuron; SOD1; superoxide dismutase 1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; ZINC; REACTIVE OXYGEN METABOLITE; RNA; SOD1 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; AUTOPHAGY; ENDOPLASMIC RETICULUM STRESS; GLIA; HUMAN; MICROGLIA; MOLECULAR PATHOLOGY; MOLECULAR SENSOR; MOTONEURON; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; MUTATION; REACTIVE OXYGEN SPECIES; RNA; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE-1;

EID: 84942609596     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414561795     Document Type: Review

References (57)

1. Atkin JD, Farg MA, Soo KY, Walker AK, Halloran M, Turner BJ, and others. 2014. Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis. J Neurochem 129: 190-204.
2. Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, and others. 2014. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol 128: 791-803.
3. Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L, and others. 2013. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 288: 15699-711.
4. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, and others. 2010. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13: 1396-403.
5. Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, and others. 2014. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14: 796-809.
6. Chesi A, Staahl BT, Jovicic A, Courhouis J, Fasolino M, Raphael AR, and others. 2014. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci 16: 851-6.
7. Chia R, Tattum MH, Jones S, Collinge J, Fisher EMC, Jackson GS,. 2010. Superoxide dismutase 1 and tgSOD1G93A mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One 5: e10627.
8. Corson LB, Strain JJ, Culotta VC, Cleveland DW,. 1998. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc Natl Acad Sci U S A 95: 6361-6.
9. de Boer AS, Koszka K, Kiskinis E, Suzuki N, Davis-Dusenbery BN, Eggan K,. 2014. Genetic validation of a therapeutic target in a mouse model of ALS. Sci Transl Med 6: 248ra104.
10. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, and others. 2010. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One 5: e11552.
11. Fritz E, Izaurieta P, Weiss A, Mir FR, Rojas P, Gonzalez D, and others. 2013. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J Neurophysiol. 109: 2803-14.
12. Fujisawa T, Homma K, Yamaguchi N, Kadowaki H, Tsuburaya N, Naguro I, and others. 2012. A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann Neurol 72: 739-49.
13. Grad LI, Cashman NR,. 2014. Prion-like activity of Cu/Zn superoxide dismutase. Implications for amyotrophic lateral sclerosis. Prion 8: 33-41.
14. Grad LI, Guest WC, Yanai A, Pokrishevsky E, ONeill MA, Gibbs E, et al. 2011. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A 108: 16398-403.
15. Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, ONeill MA, and others. 2014. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 111: 3620-5.
16. Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, and others. 2011. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29: 824-8.
17. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, and others. 2009. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23: 2294-306.
18. Homma K, Fujisawa T, Tsuburaya N, Yamaguchi N, Kadowaki H, Takeda K, and others. 2013. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol Cell 52: 75-86.
19. Hu S, Xie Z, Onishi A, Yu X, Jiang L, Lin J, and others. 2009. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139: 610-22.
20. Hwang YM, Stathopulos PB, Dimmick K, Yang H, Badiei HR, Tong MS, and others. 2010. Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis. J Biol Chem. 285: 41701-11.
21. Ilieva H, Polymenidou M, Cleveland DW,. 2009. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187: 761-72.
22. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, and others. 2012. Amyotrophic lateral sclerosis. Lancet 377: 942-55.
23. Kim HJ, Raphael AR, Ladow ES, McGurk L, Weber RA, Trojanowski JQ, and others. 2014. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet 46: 152-160.
24. Kiskinis E, Sandoe J, Williams L, Boulting G, Moccia R, Wainger B, and others. 2014. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14: 781-95.
25. Lewis C-A, Manning J, Rossi F, Krieger C,. 2012. The neuroinflammatory response in ALS: the roles of microglia and T cells. Neurol Res Int 2012: 803701.
26. Li J, Huang KX, Le WD,. 2013. Establishing a novel C. elegans model to investigate the role of autophagy in amyotrophic lateral sclerosis. Acta Pharmacol Sin. 34: 644-50.
27. Ling SC, Polymenidou M, Cleveland DW,. 2014. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416-38.
28. Lu L, Wang S, Zheng L, Li X, Suswam EA, Zhang X, and others. 2009. Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR). Implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J Biol Chem 284: 33989-98.
29. Lu L, Zheng L, Viera L, Suswam E, Li Y, Li X, and others. 2007. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci 27: 7929-38.
30. Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, and others. 2014. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A 111: 829-32.
31. Münch C, OBrien J, Bertolotti A,. 2011. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A 108: 3548-53.
32. Musarò A,. 2013. Understanding ALS: new therapeutic approaches. FEBS J 280: 4315-22.
33. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, and others. 2007. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-22.
34. Nassif M, Valenzuela V, Rojas-Rivera D, Vidal R, Matus S, Castillo K, and others. 2014. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy 10: 1256-71.
35. Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, and others. 2008. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 22: 1451-64.
36. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW,. 1995. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci U S A 92: 954-8.
37. Polymenidou M, Cleveland DW,. 2012. Prion-like spread of protein aggregates in neurodegeneration. J Exp Med 209: 889-93.
38. Reddi AR, Culotta VC,. 2013. SOD1 integrates signals from oxygen and glucose to repress respiration. Cell 152: 224-35.
39. Redler RL, Dokholyan NV,. 2012. The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci 107: 215-62.
40. Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B,. 2014. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci 8: 24.
41. Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P,. 2013. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136: 2342-58.
42. Saxena S, Cabuy E, Caroni P,. 2009. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12: 627-36.
43. Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, and others. 2013. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80: 80-96.
44. Song CY, Guo JF, Liu Y, Tang BS,. 2012. Autophagy and its comprehensive impact on ALS. Int J Neurosci 122: 695-703.
45. Sundaramoorthy V, Walker AK, Yerbury J, Soo KY, Farg MA, Hoang V, and others. 2013. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol Life Sci 70: 4181-95.
46. Thonhoff JR, Gao J, Dunn TJ, Ojeda L, Wu P,. 2011. Mutant SOD1 microglia-generated nitroxidative stress promotes toxicity to human fetal neural stem cell-derived motor neurons through direct damage and noxious interactions with astrocytes. Am J Stem Cells 1: 2-21.
47. Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XF,. 2014. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun 5: 3446.
48. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP,. 2006. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9: 108-18.
49. Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, Scheveneels W, and others. 2007. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A 104: 14825-30.
50. Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ,. 2009. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 1305: 168-82.
51. Walker AK, Atkin JD,. 2011. Stress signaling from the endoplasmic reticulum: a central player in the pathogenesis of amyotrophic lateral sclerosis. IUBMB Life 63: 754-63.
52. Wang J, Xu GL, Borchelt DR,. 2006. Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation. J Neurochem 96: 1277-88.
53. Wang L, Popko B, Roos RP,. 2011. The unfolded protein response in familial amyotrophic lateral sclerosis. Hum Mol Genet 20: 1008-15.
54. Wang L, Popko B, Roos RP,. 2014. An enhanced integrated stress response ameliorates mutant SOD1-induced ALS. Hum Mol Genet 23: 2629-38.
55. Yang YM, Gupta S, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, and others. 2013. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12: 713-26.
56. Zhang F, Ström AL, Fukada K, Lee S, Hayward LJ, Zhu H,. 2007. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem 282: 16691-9.
57. G93A mouse model of amyotrophic lateral sclerosis. Autophagy 7: 412-25.